The TAILORx trial: Individualized options for treatment

Keyphrases

• TAILORx 100%
• Molecular Diagnostics 100%
• Overtreatment 66%
• Chemotherapy 33%
• Adjuvant Chemotherapy 33%
• Clinical Significance 33%
• Clinical Decision-making 33%
• Patient Benefit 33%
• ER+ Breast Cancer 33%

Medicine and Dentistry

• Clinician 100%
• Adjuvant Chemotherapy 50%
• Breast Cancer 50%
• Clinical Decision Making 50%
• Clinical Significance 50%
• Molecular Diagnosis 50%
• Diagnostic Testing 50%

Nursing and Health Professions

• Clinical Decision Making 100%
• Breast Cancer 100%
• Adjuvant Chemotherapy 100%
• Molecular Diagnosis 100%